GLUE Monte Rosa Therapeutics, Inc.
$19.81
▼ 2.84%
38
Value
14
P/E-11.69
8
P/B2.91
46
P/S30.03
0
EV/EBITDA-8.40
5
Growth
61
Revenue Growth63.5%
100
EPS Growth53.1%
47
FCF Growth-172.3%
25
Momentum
77
12-Month Return378.5%
100
3-Month Return4.8%
68
1-Month Return15.7%
82
RSI (14)50.22
50
50/200 MABullish
75
Profitability
19
ROE-41.0%
43
ROA-17.7%
0
Gross Margin80.5%
66
Operating Margin-345.2%
0
Net Margin-302.7%
0
FCF Yield-1.5%
2
Risk
16
Beta1.62
35
60-Day Volatility49.6%
0
QScore Analysis